NC3Rs-funded researchers, Professor Hugh Perry and Dr Tracey Newman, University of Southampton, have developed a microfluidic device that creates a suitable environment to study what happens during neuronal injury. This better understanding can inform how drugs are tested at the later stages of development, reducing the number of rodents that would be required.